MI Genomic Profiling Similarity Score, the latest addition to the comprehensive genomic profiling armamentarium at Caris Life Sciences, has been launched, according to a press release from the company
Living in food deserts, clinical trial deserts, and areas with high transportation vulnerability significantly lowers breast cancer clinical trial participation.
Pembrolizumab consistently improves overall and disease-free survival in clear cell renal cell carcinoma, showing sustained benefit at 5 years post surgery.
Jill Feldman discusses the background of the phase 2 COCOON trial in advanced non–small cell lung cancer with EGFR mutations.
During a live event, Danielle M. Brander, MD, discussed use of zanubrutinib in high-risk chronic lymphocytic leukemia.
Hyung Kim, MD, discussed the PROBE trial, a trial in progress, for patients with advanced kidney cancer.
Panelists discuss how axatilimab demonstrates particularly good responses for gastrointestinal graft-vs-host disease (GVHD) and may improve sclerotic skin changes despite lower rates of overall skin…
Seven-year follow-up data on over 1400 patients show radium-223’s long-term safety, with a low 2% secondary malignancy rate, reflecting real-world use.
President Donald J. Trump has signaled that lowering the costs of prescription drugs will be a priority for his second term.
Paolo Ghia, MD, PhD, discusses the final analysis of the CAPTIVATE study.
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.
